We are live on
!
Find out more
NA
Navellier & Associates Portfolio holdings
AUM
$960M
1-Year Est. Return
79.37%
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$2B
AUM Growth
+$12.2M
(+0.62%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-6.13%
Top 10 Holdings %
Top 10 Hldgs %
36.44%
Holding
384
New
60
Increased
76
Reduced
187
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HNT
HEALTH NET INC
HNT
|
+$39.4M |
| 2 |
HP
HPQ
|
+$34M |
| 3 |
Southern Company
SO
|
+$33.9M |
| 4 |
Centene
CNC
|
+$33.7M |
| 5 |
UGI
UGI
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$71.9M |
| 2 |
Lear
LEA
|
+$42.1M |
| 3 |
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$37.4M |
| 4 |
Diamondback Energy
FANG
|
+$36.8M |
| 5 |
LyondellBasell Industries
LYB
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.15% |
| 2 | Technology | 21.65% |
| 3 | Industrials | 12.91% |
| 4 | Utilities | 10.27% |
| 5 | Consumer Staples | 7.39% |
Similar funds
JVBC
LOAMU
MK
QIM
TFP
UWPG
FWM
RCIM
Navellier & Associates's Q4 2014 Portfolio in Review
As of Q4 2014, Navellier & Associates held 384 positions worth $2B, up 0.62% from $1.99B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Navellier & Associates withdrew a net $123M in Q4 2014, closing 58 positions and reducing 187 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $71.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
Against the trend, Navellier & Associates opened a new position in HEALTH NET INC worth $42.8M.
- Navellier & Associates's largest Q4 2014 buy was HEALTH NET INC: 799,779 shares worth $42.8M.
- Navellier & Associates added most to Southern Company in Q4 2014, an estimated $33.9M increase.
- Navellier & Associates's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $31.3M.
- Navellier & Associates fully exited Thermo Fisher Scientific in Q4 2014, selling an estimated $71.9M.
- Navellier & Associates's ten largest holdings make up 36% of its $2B portfolio in Q4 2014.
- Navellier & Associates opened 60 new positions and closed 58 in Q4 2014.
- Navellier & Associates's portfolio value rose 0.62% quarter-over-quarter to $2B.
Based on Navellier & Associates's 13F filing for Q4 2014, filed 2 Feb 2015.